CCM
VCYT icon

Coldstream Capital Management’s Veracyte VCYT Stock Holding History

Coldstream Capital Management’s Portfolio VCYT Stock Details VCYT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-1,350
Closed -$40K – 3269
2025
Q1 		$40K Buy
+1,350
New +$51.5K ﹤0.01% 1815

Other funds holding VCYT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Coldstream Capital Management's VCYT Position: Q2 2025 in Review

Coldstream Capital Management sold out of Veracyte (VCYT) in Q2 2025, closing a stake of 1,350 shares — an estimated $40K sold.

Coldstream Capital Management first reported a position in VCYT in Q1 2025 and held it in 1 quarter. The position peaked at $40K in Q1 2025. 278 funds tracked by Wall St. Rank hold VCYT as of Q2 2025.

  • Coldstream Capital Management reported no remaining Veracyte position as of Q2 2025 after selling out during the quarter.
  • Coldstream Capital Management sold 1,350 Veracyte shares in Q2 2025, an estimated $40K.
  • Coldstream Capital Management first reported a position in Veracyte in Q1 2025 and held it in 1 quarter.
  • Coldstream Capital Management's Veracyte position peaked at $40K in Q1 2025.
  • 278 funds tracked by Wall St. Rank held Veracyte as of Q2 2025.

Based on Coldstream Capital Management's 13F filing for Q2 2025, filed 12 Aug 2025.